| Revenue guidance | 20.0% → 5.0% Cut by 15.0 percentage points |
|---|
| Revenue growth | -42% YoY; -57% QoQ. |
|---|---|
| Margins | EBITDA margin contracted 624 bps YoY to 23.3%. |
| Order book | CRAMS pipeline on track; projects contribute from H2FY27. |
| Demand visibility | Subdued European demand persisting into Q2FY27. |
| Management confidence | Confident in H2FY27 recovery via direct sales and CRAMS. |
Growth
Revenue from operations fell 42% YoY to ₹14.36 Cr; PAT dropped 68% YoY to ₹1.12 Cr.
Outlook
Moderated FY27 non-linear growth guidance. Block 7 commissioning H1FY27; ₹15 Cr FY26 capex for R&D and expansion.
Risks
Subdued European demand; raw material volatility; termination of key EU marketing agreement leading to temporary volume loss.
Investor Presentation filed with BSE, NSE: SGRL. Summary written with AI assistance from the document.
Shree Ganesh Remedies Ltd: key numbers
- Share price
- ₹717.35
- Market cap
- ₹920.9 Cr
- Revenue (annual)
- ₹109.3 Cr
- Net profit (annual)
- ₹17.76 Cr
- P/E (TTM)
- 59.7×Sector 47.4×
- Promoter holding
- 72.84%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ganesh Remedies Ltd
All →Shree Ganesh Remedies Annual General Meeting
Shree Ganesh Remedies held its 31st Annual General Meeting on September 12, 2026. The meeting transacted ordinary and special business items, including director and auditor appointments.
Shree Ganesh Remedies Annual General Meeting
Shree Ganesh Remedies Limited has issued the notice for its 31st Annual General Meeting scheduled for September 12, 2026. Shareholders will consider key resolutions and director appointments.
Shree Ganesh Remedies Annual Report
Shree Ganesh Remedies Limited has filed its Annual Report for FY 2025-26. It also includes the notice for the 31st Annual General Meeting on September 12, 2026.
Shree Ganesh Remedies Results Update
Shree Ganesh Remedies announced its Q1FY27 financial results. Revenue from operations stood at ₹14.36 Crore, with a PAT of ₹1.12 Crore.
- Value
- ₹14.36 Cr
Shree Ganesh Remedies Other Announcement
Shree Ganesh Remedies Limited has appointed M/s. M. I. Prajapati & Associates LLP as the company's Cost Auditor for a term of 12 months.
- Execution
- 12 months
Shree Ganesh Remedies Q1 FY27 Results: Net Profit ₹1.1 Cr, Down 67.6% YoY
Shree Ganesh Remedies Ltd reported revenue from operations of ₹14.4 Cr (-41.7% YoY) and net profit of ₹1.1 Cr (-67.6% YoY) for Q1 FY27.
- Key figure
- Net profit ₹1.1 Cr · -67.6% YoY